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Abstract
Original research contributions published in Critical Care in 2008
in the fields of respirology and critical care medicine are sum-
marized. Eighteen articles were grouped into the following
categories: acute lung injury and acute respiratory distress syn-
drome, mechanical ventilation, mechanisms of ventilator-induced
lung injury, and tracheotomy decannulation and non-invasive
ventilation.
Introduction
Original research in the field of critical care respirology
published in 2008 yielded a broad spectrum of interesting
results ranging from epidemiological analyses, identification
of biomarkers and ventilator management, to pharmacological
intervention for acute lung injury (ALI). To provide context and
for comparison with the papers described here, we also cite
studies on the same subjects published in journals other than
Critical Care.
Acute lung injury and acute respiratory
distress syndrome
ALI and acute respiratory distress syndrome (ARDS) are
major causes of morbidity and mortality, and account for a
large proportion of intensive care unit (ICU) bed use. Many
pharmacological interventions for these entities have been
evaluated, but none has clearly been shown to decrease
mortality [1]. To help develop novel treatment strategies for
patients with ALI/ARDS, the Irish Critical Care Trials Group
conducted a study in a cohort of patients with ALI/ARDS in
the Irish adult ICU population [2]. The investigators described
the epidemiology and management of ALI/ARDS in order to
identify factors associated with outcome, and to identify
whether standardized care is being delivered across
participating centres in a research network. There were
1,029 admissions during a 10-week study period in 14
participating centres. A total of 196 (19%) patients had
ALI/ARDS; of these 141 (72%) had ALI/ARDS on admission.
The most common predisposing risk factors were pneumonia
(50%) and extrapulmonary sepsis (26%). Although protective
lung ventilation (mean tidal volume 7.0 ± 1.7 ml/kg) was used
commonly throughout participating centres, the overall ICU
mortality for ALI/ARDS was 32.3%. Lower arterial oxygen
tension (PaO2)/fractional inspired oxygen (FiO2) ratios and
higher Sequential Organ Failure Assessment scores at
admission were associated with increased mortality. These
data are helpful in planning future multicentre clinical trials in
patients with ALI/ARDS.
ALI/ARDS is characterized by an excessive inflammatory
response involving a variety of inflammatory mediators; this
allows for the identification of reliable biomarkers for diag-
nostic and therapeutic purposes in this often fatal disease.
Direct collection of lung fluids such as lung lavage and
sputum is not always feasible at the bedside for a number of
reasons. Collection of exhaled breath condensate (EBC) is
an alternative approach to obtaining lower respiratory tract
samples in patients breathing spontaneously as well as in
those undergoing mechanical ventilation [3]. Roca and
coworkers [4] studied patients with ALI who were ventilated
using the ARDS Network low tidal volume protocol [5]. EBC
was collected before and 30 minutes after administration of
inhaled salbutamol, a short-acting β2-adrenergic receptor
agonist. A significant increase in EBC pH and a trend toward
decreased inflammatory markers, including nitrosative species
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and 8-isoprostane concentration, were observed after
salbutamol administration. Although the study was conducted
in a small cohort of patients, the results suggested that EBC
analysis may be useful for evaluating the effectiveness of
therapy in ventilated patients.
Further down the cascade of inflammatory responses
observed in patients with ALI/ARDS, the deposition of fibrin
in the alveolar space can result in hyaline membrane forma-
tion, and deposition in microcirculation leads to thrombosis. It
is thus reasonable to speculate that the properties of heparin,
which exhibits both anticoagulant and fibrinolytic actions, may
help to limit fibrin deposition in the alveolar space and micro-
circulation. In an open label phase I trial, Dixon and coworkers
[6] examined the effects of four escalating doses of nebulized
heparin from 50,000 to 400,000 U/day in 16 ventilated
patients with ALI. They found no serious side effect for any
dose used. The time course of PaO2/FiO2 ratio, lung
compliance and the alveolar dead space fraction levels were
similar across all doses used. There were trends toward an
increase in the activated partial thromboplastin time and
thrombin clotting time, and toward a reduction in prothrombin
fragment levels at higher doses. Of note, phase I studies are
used to assess initial safety issues, pharmacokinetics,
pharmacodynamics, feasibility and dose ranging, and are not
powered and are not expected to provide positive outcome
signals. Further trials are required to define the safety and
efficacy of nebulized heparin in patients with ALI/ARDS.
From the physiological perspective, patients with ALI/ARDS
may have right-to-left pulmonary shunts that can lead to
alveolar dead space. To analyze the influence of pulmonary
shunt on dead space in ARDS conditions, Niklason and
coworkers [7] analyzed the effects of varying systemic blood
flow, anaemia, high metabolic rate and acid-base instability by
computer modelling. They reported that the alveolar dead
space increased with right-to-left shunt fraction. Several
factors can contribute to the alveolar dead space, including
reduced cardiac output, decreased haemoglobin levels and
metabolic acidosis due to hyperventilation. This study
enhances our understanding of how physiological alterna-
tions may lead to pulmonary shunt in ARDS.
Mechanical ventilation
Mechanical ventilation is often a life-saving intervention, but it
may cause or exacerbate lung damage in patients with
ALI/ARDS. Arterial oxygenation is frequently used as an
intervention target for mechanical ventilation. Although
hypoxia is a major concern to the clinician, hyperoxia is also
highly toxic but may be overlooked at bedside. de Jonge and
coworkers [8] investigated the relationship between FiO2
administered, PaO2 levels achieved and hospital mortality in
36,307 consecutive patients admitted to 50 Dutch ICUs
treated with mechanical ventilation. The authors demon-
strated that the achieved PaO2 values in the ICU patients
were higher than those recommended in the literature. The
mortality rate was linearly related to FiO2. Both low PaO2 and
high PaO2 during the first 24 hours after ICU admission were
associated with hospital mortality, forming a U-shaped curve.
This study suggests that hyperoxia might have been
overlooked in the ICU, and optimizing oxygenation targets
may help to improve outcomes.
In patients with pulmonary shunts, increases in FiO2 have a
minimal effect on arterial oxygenation. One approach to
increase PaO2 is to perform recruitment manoeuvres.
Constantin and coworkers [9] compared two recruitment
manoeuvres in 19 patients with ARDS using a randomized
crossover design. The recruitment manoeuvres were applied
based on pulmonary mechanics in each patient, beginning
with either continuous positive airway pressure or extended
sigh. Both recruitment manoeuvres increased oxygenation,
but the increase in PaO2/FiO2 was significantly greater with
extended sigh than with continuous positive airway pressure.
The investigators also used lung computed tomography (CT)
scans and pressure-volume curves to examine the impact of
the recruitment manoeuvres.
Several studies examined the utility of monitoring end-
expiratory lung volume (EELV) to help to optimize ventilatory
settings or predict the effects of lung recruitment manoeuvres
in ALI/ARDS. The application of positive end-expiratory
pressure (PEEP) can lead to increased EELV as a result of
recruitment or further distension of already ventilated alveoli.
Koefoed-Nielsen and coworkers [10] examined whether the
measurement of EELV combined with the use of pressure-
volume curves would be helpful in predicting changes in lung
mechanics in response to recruitment manoeuvres. They
speculated that EELV measurement could determine whether
lung volume is reduced in clinical situations with low
respiratory system compliance and low PaO2/FiO2 ratios,
whereas an analysis of pressure-volume curves could predict
whether recruitment manoeuvres and increased PEEP would
be effective. In a pig model of ALI induced by lung lavage and
high airway pressure ventilation, the difference in lung volume
was measured from pressure-volume curves and the changes
in EELV were assessed after each recruitment manoeuvre.
The authors showed that the maximal volume hysteresis
obtained from pressure-volume curves predicted changes in
lung mechanics better than changes in gas exchange in
response to recruitment manoeuvres. Similar observations
were obtained in a pig model of ARDS induced by oleic acid
injection, in which Lambermont and coworkers [11]
measured functional residual capacity, statistic pulmonary
compliance and PaO2 during a sequential reduction in PEEP
from high to low levels. The investigators reported that
combined EELV and lung compliance measurements may
help to optimize the PEEP level.
These interesting observations in animal models were also
reported in the clinical setting. Bikker and coworkers [12]
measured EELV at PEEP levels that were reduced sequen-tially from 15 to 5 cmH2O in 45 mechanically ventilated
patients with and without lung injury. In all patients, EELV
decreased significantly corresponding to the sequential
reduction in PEEP, whereas the PaO2/FiO2 ratio remained
unchanged. Interestingly, a correlation between the change in
EELV and the change in respiratory system compliance was
found in patients with extrapulmonary injury. These clinical
results suggest that, in combination with the assessment of
pulmonary compliance, measurement of EELV may provide
useful information to help optimize the ventilatory settings in
ALI/ARDS conditions.
Given these findings, an important issue at the bedside is
what is the best way clinically to perform an EELV measure-
ment. The helium dilution technique has been used for a
decade but the procedure is both time consuming and labour
intensive. Chiumello and coworkers [13] compared EELV
measured by the conventional helium dilution technique with
that obtained by a modified nitrogen wash-out/wash-in
system in 30 patients with ALI/ARDS. EELV was also
compared with CT scans, which were considered to be the
‘gold standard’. The authors reported that the EELV
measured with either the helium dilution technique or the
modified nitrogen wash-out/wash-in system exhibited good
correlation with the CT scan data. In particular, the helium
dilution technique appeared to be more precise at low lung
volumes, and the modified nitrogen wash-out/wash-in system
worked well at all lung volumes. This study provides an
alternative approach to measurement of EELV at the bedside.
As discussed above, several studies have examined the
importance of shunt fraction, dead space and EELV within
the context of ALI/ARDS. Varelmann and coworkers [14]
conducted an elegant study to address the question of
whether spontaneous breathing during pressure-controlled
ventilation improves oxygenation, ventilation/perfusion match-
ing, dead space and EELV. ALI was induced either by
hydrochloric acid aspiration as a direct lung injury model or
by increasing intra-abdominal pressure combined with
intravenous oleic acid injection as an indirect lung injury
model in pigs. The authors demonstrated that spontaneous
breathing during pressure-controlled ventilation improved
PaO2/FiO2 ratio by reducing pulmonary shunt fraction and
increasing EELV, as compared with the animals without
spontaneous breathing. Systemic oxygen delivery was higher
due to greater cardiac output during spontaneous breathing.
Mechanisms of ventilator-induced lung
injury
Ventilator-induced lung injury (VILI) is characterized by
biotrauma and vascular barrier disruption leading to pulmo-
nary oedema. In addition to proposed low tidal volume
ventilatory strategies, our understanding of the underlying
inflammatory responses in VILI has greatly advanced. Three
excellent studies examined the effects of pharmacological
interventions in rat models of VILI-associated ALI/ARDS.
One of the therapeutic interventions aimed at reducing
vascular leakage. Clearance of alveolar oedema depends on
a number of factors, including active transport of sodium
across endothelium and epithelial barriers and the stability of
cell membranes. β-Adrenergic agonists such as dopamine
and salbutamol exert anti-inflammatory effects as well as
augmenting pulmonary oedema clearance [15,16]. Chamorro-
Martin and coworkers [17] examined the effects of intra-
tracheal administration of dopamine on pulmonary oedema
and survival in a rat model of surfactant deficiency and VILI-
induced surfactant removal by lung lavage with a saline
solution, which was followed by ventilation with high tidal
volumes (25 ml/kg) for 60 minutes. A lower wet/dry lung
weight ratio, reflecting decreased lung permeability, and a
greater survival rate was obtained in rats treated with
dopamine compared with the control group. This study
suggests that the administration of dopamine may enhance
clearance of alveolar oedema within the context of VILI.
It is noteworthy that β-adrenergic agonists are broncho-
dilators, and delivery of bronchodilators with metered-dose
inhalers has been used in mechanically ventilated patients.
Malliotakis and coworkers [18] administered the long-acting
β2-adrenergic agonist salmeterol by metered-dose inhaler
and a spacer in 10 mechanically ventilated patients who had
acute exacerbations of chronic obstructive pulmonary disease.
The bronchodilator effect was evident at 30 minutes after
salmeterol delivery and was well maintained over 8 hours.
As described above, increased lung permeability is a
hallmark of VILI. It is known that plasma membranes are
barriers for hydrophilic molecules and ions because of the
hydrophobic core of the phospholipid bilayer. The main
structural components of plasma membranes are phos-
pholipids such as 1-palmitoly-2-arachidonoyl-sn-glycero-3-
phosphorylcholine (PAPC). Oxidized PAPC has been shown
to exhibit anti-inflammatory effects in ALI [19]. Nonas and
coworkers [20] examined the effects of oxidized PAPC on
lung inflammation and barrier disruption in a rat model of VILI
caused by using high tidal volume ventilation. Pretreatment of
rats with a single intravenous injection of oxidized PAPC
markedly attenuated lung permeability, reflected by
decreased protein concentrations and decreased neutrophil
infiltration in the lung, compared with an untreated control
group. The mechanisms by which oxidized PAPC exerts
protective effects may be through suppression of Rho
signalling, leading to decreased endothelial paracellular gap
formation. Although the therapy in this study was given before
induction of injury, the authors generated a proof-of-concept
for this approach, and hence the study is very encouraging.
Further studies are required to examine the effects of oxidized
PAPC in established ALI/ARDS.
An increasing body of evidence suggests that VILI is
associated with muscle atrophy that alters diaphragm
contractile properties [21]. Controlled mechanical ventilation
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including the lysosomal (i.e. cathepsins), the calcium-depen-
dent proteinases (calpains) and the activation of ubiquitin-
proteasome system. Futier and coworkers [22] hypothesized
that mechanical ventilation in pressure support ventilation
would attenuate diaphragmatic proteolysis, thus preserving
muscle activity compared with controlled mechanical ventila-
tion. The authors demonstrated that diaphragmatic protein
catabolism was significantly increased and protein synthesis
decreased after 18 hours of controlled mechanical ventilation
compared with control rats. The high protein catabolism and
low synthesis were associated with an increased activity of
both 20S proteasome and tripeptidylpeptidase II. The animals
treated with pressure support ventilation exhibited reduction
in the mechanical ventilation-induced proteolysis and
inhibition of protein synthesis. This study suggests that
pressure support ventilation may be superior to controlled
ventilation with respect to limiting ventilator-induced dia-
phragmatic dysfunction.
VILI is often accompanied with distal organ injury associated
with overwhelming inflammatory responses involving many
inflammatory mediators. For example, excessive activation of
poly (ADP-ribose) polymerase (PARP) enzyme after massive
DNA damage may aggravate inflammatory responses.
PARP-1 is the most abundant PARP family member to
‘sense’ DNA damage, repair DNA and maintain genomic
stability. However, when severe DNA injury occurs in
response to oxidative stress, excessive upregulation of PARP
may be harmful by depleting cellular ATP stores, resulting in
cell dysfunction and death. The potent PARP inhibitor PJ-34
has been shown to decrease PARP-1 activity and nuclear
factor-κB activation in animal models of endotoxic and
haemorrhagic shock. Kim and coworkers [23] hypothesized
that pharmacological inhibition of PARP by PJ-34 would
attenuate VILI. Mice were ventilated with either low or high
airway pressure in the presence or absence of PJ-34 treat-
ment given before mechanical ventilation. The investigators
demonstrated that the PJ-34-treated animals had improved
lung histology and attenuated inflammatory responses
associated with a decreased nuclear factor-κB activation, as
compared with the untreated groups. This study was
consistent with a recent publication showing that the
administration of PJ-34 attenuated VILI in a rat model in which
two-hit injury was induced by intratracheal lipopolysaccharide
instillation followed by mechanical ventilation [24]. Taken
together, these studies suggest that pharmacological inter-
ventions targeting specific inflammatory molecules may
eventually have a role to play in the treatment of VILI.
Tracheotomy decannulation and noninvasive
ventilation
Tracheotomy is performed in approximately one-tenth of
mechanically ventilated patients to facilitate prolonged airway
management. The relatively new technique for percutaneous
dilatational tracheotomy may result in tracheotomy becoming
an even more common surgical procedure in the ICU. The
majority of tracheotomized patients who survive their illness
can eventually be effectively decannulated. However, there is
a lack of consensus as to when a tracheotomy tube should
be removed. Stelfox and coworkers [25] conducted a cross-
sectional survey of 225 responding clinicians involved in
routine tracheotomy management at 118 medical centres.
The patients’ levels of consciousness, ability to tolerate
tracheotomy tube capping, cough effectiveness and
secretions were rated as the most important factors in the
decision to remove a tracheotomy tube from a patient. The
survey indicated that patients were most likely to be
recommended for decannulation if they were alert and
interactive, had a strong cough, had scant thin secretions and
required minimal supplemental oxygen. Decannulation failure
was defined as the need to re-establish an artificial airway
within 48 to 96 hours of planned tracheotomy removal, which
ranged between 2% and 5%.
A number of complications may occur during invasive mecha-
nical ventilation, such as complications of intubation, ventilator-
associated pneumonia, VILI (barotrauma, volutrauma and
biotrauma), cardiovascular effects and so on. Noninvasive
positive-pressure mechanical ventilation (NPPV) has been
investigated as an alternative in the management of patients
with ALI. Trevisan and coworkers [26] addressed the
question of whether NPPV would be beneficial in weaning
patients from invasive mechanical ventilation. Of 65 patients
who failed a spontaneous breathing T-piece trial during
weaning, 28 were randomly assigned to NPPV and 37 were
assigned to invasive mechanical ventilation. The incidence of
complications (pneumonia and tracheotomy) was lower in the
NPPV group than in the invasive mechanical ventilation
group. Although there was a tendency toward decreased ICU
and hospital stays, the differences did not achieve statistical
significance. The authors concluded that the combination of
early extubation and NPPV is a useful and safe alternative for
ventilation of patients who fail initial weaning attempts.
Conclusions
A number of excellent studies published in Critical Care in
2008 have addressed the mechanisms, examined monitoring
techniques and explored potential therapeutic approaches in
the context of ARDS and VILI both in the ICU population and
in animal models. The great quality and quantity of the
respiratory research in such a dynamic and opportune time
will impact patient care.
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